Placemark Investments’s Abiomed Inc ABMD Stock Holding History

Placemark Investments’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$209K	Buy	+5,510	New	+$174K	﹤0.01%	1538

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Placemark Investments's ABMD Position: Q4 2014 in Review

Placemark Investments opened a new position in Abiomed Inc (ABMD) in Q4 2014: 5,510 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1538 among its holdings.

158 funds tracked by Wall St. Rank hold ABMD as of Q4 2014.

Placemark Investments held 5,510 shares of Abiomed Inc worth $209K as of Q4 2014.
Abiomed Inc was a new Placemark Investments position in Q4 2014.
Abiomed Inc made up ﹤0.01% of Placemark Investments's portfolio in Q4 2014, its #1538 holding.
158 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.